Welcome to BusinessBankruptcies.com!

Sign up for a free account to get access to data on case creditors, search for cases, and more.

Adamis Pharmaceuticals Corporation

COURT
Delaware Bankruptcy Court
CASE NUMBER
1:2024bk10155
TYPE / CHAPTER
Voluntary / 11

Filed

2-2-24

Updated

12-1-24

Last Checked

2-9-24

Assets

Subscribe

Liabilities

Subscribe

Docket

Last Updated
Feb 9, 2024
Last Entry Filed
Feb 6, 2024

Docket Entries by Month

Feb 2 1 Petition Chapter 11 Voluntary Petition . Fee Amount $1738. Filed by Adamis Pharmaceuticals Corporation. (Busenkell, Michael) (Entered: 02/02/2024)
Feb 2 2 Receipt of filing fee for Voluntary Petition (Chapter 11)( 24-10155) [misc,volp11a] (1738.00). Receipt Number A11442862, amount $1738.00. (U.S. Treasury) (Entered: 02/02/2024)
Feb 2 3 Motion for Joint Administration Filed by Adamis Corporation, Adamis Pharmaceuticals Corporation, Biosyn, Inc., DMK Pharmaceuticals Corporation, Rhombus Pharmaceuticals Corporation. (Busenkell, Michael) (Entered: 02/02/2024)
Feb 2 4 Notice of Appearance. Filed by BMC Group, Inc.. (Ordaz, Steven) (Entered: 02/02/2024)
Feb 3 Judge Mary F. Walrath added to case (SH) (Entered: 02/03/2024)
Feb 6 5 Order Authorizing Joint Administration of Related Chapter 11 Cases. An order has been entered in this case consolidating this case with the case of DMK Pharmaceuticals Corporation, 24-10153 (MFW), for procedural purposes only and providing for its joint administration in accordance with the terms thereof. The docket in Case No. 24-10153 (MFW) should be consulted for all matters affecting this case. Signed on 2/6/2024 (CAF) Modified on 2/7/2024 (LAM). (Entered: 02/06/2024)

Case Information

Court
Delaware Bankruptcy Court
Case number
1:2024bk10155
Assets
Subscribe for Access
Liabilities
Subscribe for Access
Judge
Mary F. Walrath
Chapter
11
Filed
Feb 2, 2024
Type
voluntary
Updated
Dec 1, 2024
Last checked
Feb 9, 2024
Lead case
DMK Pharmaceuticals Corporation

Associated Cases

    This case has no creditors listed.

    Parties

    Debtor

    Adamis Pharmaceuticals Corporation
    50 Division Street
    Suite 501
    Somerville, NJ 08876
    SOMERSET-NJ
    Tax ID / EIN: xx-xxx9663
    fka Aardvark Merger Sub, Inc.
    fka DMK Pharmaceuticals Corporation

    Represented By

    Michael G. Busenkell
    Gellert Scali Busenkell & Brown, LLC
    1201 North Orange Street
    3rd Floor
    Wilmington, DE 19801
    302.425.5812
    Fax : 302.425.5814
    Email: mbusenkell@gsbblaw.com

    U.S. Trustee

    U.S. Trustee
    Office of the United States Trustee
    J. Caleb Boggs Federal Building
    844 King Street, Suite 2207
    Lockbox 35
    Wilmington, DE 19801
    (302)-573-6491

    Nearby Cases

    Date Filed Nameparent case = parent case Chapter Case #
    Feb 2 Biosyn, Inc. parent case 11 1:2024bk10156
    Feb 2 Adamis Corporation parent case 11 1:2024bk10154
    Feb 2 DMK Pharmaceuticals Corporation 11 1:2024bk10153
    Apr 24, 2022 Research-Cottrell Cooling, Inc. 11 1:2022bk10380
    Apr 24, 2022 Hamon Research-Cottrell, Inc. 11 1:2022bk10379
    Apr 24, 2022 Hamon Deltak, Inc. 11 1:2022bk10378
    Apr 24, 2022 Hamon Custodis, Inc. 11 1:2022bk10377
    Feb 12, 2019 Jas & Es Holdings, LLC 11 3:2019bk12888
    Oct 29, 2018 Dental Sleep Masters, LLC 7 2:2018bk31413
    Oct 29, 2018 Dental Sleep Masters, LLC 7 3:2018bk31413
    Aug 26, 2016 Brentwood Food Company Inc. 7 3:16-bk-26394
    Jul 26, 2016 Meridian Evolution of Energy, LLC 11 3:16-bk-24325
    Jan 14, 2016 Circle Lighting, Inc. 7 3:16-bk-10636
    Jan 27, 2014 Crown ATM Network, LLC. 7 3:14-bk-11318
    Feb 25, 2013 Affordable Life, LLC 7 3:13-bk-13671